Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

  • Andreea Nistor1,
  • Peter H Watson1,
  • Norman Pettigrew2,
  • Karim Tabiti3,
  • Angelika Dawson4 and
  • Yvonne Myal1, 5Email author
BMC Clinical Pathology20066:2

DOI: 10.1186/1472-6890-6-2

Received: 22 August 2005

Accepted: 18 January 2006

Published: 18 January 2006

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
22 Aug 2005 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Sep 2005 Reviewed Reviewer Report - Chris De Wolf-Peeters
4 Oct 2005 Reviewed Reviewer Report - Douglas Demetrick
2 Dec 2005 Author responded Author comments - Andreea Nistor
Resubmission - Version 3
2 Dec 2005 Submitted Manuscript version 3
22 Dec 2005 Reviewed Reviewer Report - Chris De Wolf-Peeters
29 Dec 2005 Author responded Author comments - Andreea Nistor
Resubmission - Version 4
29 Dec 2005 Submitted Manuscript version 4
10 Jan 2006 Author responded Author comments - Andreea Nistor
Resubmission - Version 5
10 Jan 2006 Submitted Manuscript version 5
Publishing
18 Jan 2006 Editorially accepted
18 Jan 2006 Article published 10.1186/1472-6890-6-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pathology, University of Manitoba
(2)
Department of Pathology, Immunopathology Laboratory, Health Sciences Centre
(3)
Head Alliance Management Oncology, Clinical Genomics, Roche diagnostics GmBH
(4)
Department of Biochemistry & Medical Genetics, University of Manitoba
(5)
Molecular Diagnostic Pathology Laboratory, Department of Pathology, Health Sciences Centre

Advertisement